Abstract: Speech disorder exacerbates when negative affect is aroused in patients with schizophrenia. However, little is known about the effects of positive affect on speech disorder. A wellvalidated laboratory procedure was used to determine whether arousal of positive affect would modulate speech disorder in 57 stable outpatients with schizophrenia and 48 community controls. Overall, the level of speech disorder modulation was negligible for both groups, although there was considerable variability in whether patients' speech disorder exacerbated or ameliorated. Results suggest that arousal of positive affect has an ameliorative effect on speech disorder for certain patients who have relatively severe symptomatology.
C hanges in affective states are associated with changes in symptom severity in patients with schizophrenia (for a review, see Fowles 1992) . However, advancement in our empirical understanding of the causal pathways by which affect and symptoms influence each other has only recently been made possible. Owing in large part to greater sophistication of analogue paradigms and the development of sensitive measures of pathological processes, recent laboratory studies have confirmed the notion that arousal of negative affect can exacerbate symptomatology. Of particular note, evidence from a series of studies using the Communications Disturbances Index (CDI; Docherty 1996a), an instrument capable of detecting subtle forms of disorder in natural speech, has demonstrated that the speech of patients with schizophrenia tends to become markedly more disordered when negative affect is aroused. This phenomenon is known as affective reactivity of speech. As yet, both laboratory investigations using the CDI and studies that examine the affect-symptom link more generally have focused on the impact of stress and negatively valenced affect, and there is little understanding about how positive affect influences symptomatology. This is somewhat surprising given the role that positive mood induction has in many psychosocial-based interventions (e.g., emotion management, Hodel et al., 1998; stress management, Norman et al., 2002) . The aim of the present study was to examine the relationship between positive affect and speech disorder in patients with schizophrenia.
METHODS

Participants
This study was part of a multifaceted research project investigating language disorder in schizophrenia (Docherty et al., 2003) . The patient group, which was 40% female and 70% Caucasian, consisted of 57 stable outpatients with schizophrenia or schizo-affective disorder (American Psychiatric Association, 1994) . Means Ϯ SDs were computed for the age (37 Ϯ 7 years), education (12.3 Ϯ 2 years), Global Assessment of Functioning (GAF; American Psychiatric Association, 1994; 50 Ϯ 12), and Shipley Institute of Living Scale-Estimated IQ (IQ; Zachary et al., 1985; 85.7 Ϯ 15) variables. Twenty-two of the patients were being prescribed typical antipsychotic medication, 36 were being prescribed atypical antipsychotics, and five patients were not being prescribed any antipsychotics. The control group, which was 60% female and 84% Caucasian, was composed of 48 university support employees who were matched to the patient group on age and parental socioeconomic status. Means Ϯ SDs were computed for controls' age (39 Ϯ 7 years), education (14.7 Ϯ 2 years), GAF (87 Ϯ 5), and IQ score (102.9 Ϯ 2) variables.
Ratings of Affective Reactivity
Participants were asked to produce four separate, 10-minute-long narratives. During the first and third narratives, the participants talked about affectively neutral topics (i.e., hobbies, daily routine, and so forth). The initial narrative condition was administered to familiarize the participants with the procedure, and the third sample was used to derive patients' baseline/neutral speech disorder levels. The second and fourth narratives consisted of the participants talking about affectively valenced memories. These narratives were collected on separate days to avoid carryover effects, and the order was counterbalanced. In one of these two conditions (the affectively positive condition), participants were asked to recount "good" memories from their lives, and in the other condition (the affectively negative condition) "stressful, bad" memories. Patients were expected to do most of the talking; however, interviewers kept them on task as needed and elicited elaboration of condition-appropriate memories. This project examined speech disorder in the affective-neutral and positive conditions. Immediately following each narrative, participants were asked to report the level of stress that they had experienced while recounting their memories using an analogue scale that ranged from zero ("not at all stressful") to 100 ("extremely stressful"). Analogue ratings were missing for two patients and two controls.
The narratives were transcribed by trained research assistants and then analyzed using the CDI (Docherty et al., 1996b) . The CDI measures six conceptually distinct types of referential disturbances, including vague references, confused references, missing information references, ambiguous word meanings, wrong word references, and structural unclarities. Instances of each type of disturbance in the speech samples are counted. To control for individual differences in verbosity, these scores were then divided by the amount of speech (hundreds of words) in the narrative. Total CDI scores, which were used in the present study, were computed as a sum of the six referential disturbance scores. The CDI and its validation are described more fully in an earlier publication (Docherty et al., 1996) .
Symptom Ratings
Symptom factor scores from the expanded Brief Psychiatric Rating Scale (Lukoff et al., 1986) were used to measure patients' symptomatology. Using findings from a recent factor analysis of the BPRS (Ventura et al., 2000) , the positive (i.e., suspiciousness, unusual thought content, hallucination, disorientation, and bizarre behavior items), negative (i.e., emotional withdrawal, motor retardation, self-neglect, and blunted affect items), manic/excitement (i.e., motor hyperactivity, elevated mood, excitement, distractibility, hostility and grandiosity items), and depression/anxiety (i.e., guilt, depression, anxiety and suicidality items) factors were computed. To avoid confusion with the positive and negative affective conditions, the positive and negative symptom factors were renamed psychosis and anergia, respectively. Interrater agreement for each of these factor scores, computed based on independent ratings from 10 of the patient cases, was acceptable (intraclass correlation coefficients Ͼ.70).
RESULTS
Patients Versus Controls
Means Ϯ SDs for the speech disorder ratings from the neutral and positive conditions were computed for the patients (2.67 Ϯ 2.04 and 2.28 Ϯ 1.65, respectively) and controls (.53 Ϯ .47 and .47 Ϯ .32, respectively). All CDI scores were logtransformed to compensate for excessively skewed distributions. A mixed-model ANOVA was used to compare the CDI scores from the two conditions across the patient and control groups. The between-group main effect was statistically significant (F ͓1͔ ϭ 542.29; p Ͻ 0.00), and the within-group and interaction main effects were not significant (F ͓103͔ ϭ 2.56, NS; and F ͓103͔ ϭ .85, NS, respectively). Simple contrasts revealed that patients had more speech disorder in both the neutral (t ͓103͔ ϭ 10.05, p Ͻ 0.00) and positive (t ͓103͔ ϭ 10.70, p Ͻ 0.00) conditions compared with controls. Thus, while the patients showed more severe speech disorder across both conditions than controls, neither group showed demonstrable levels of speech disorder modulation.
Although patients were kept on topic by the trained interviewers, it is possible that there were group differences in the degree to which positive affect was aroused across the two conditions. To examine this issue, a mixed-model (group ϫ condition) ANOVA was used to compare patients and controls on the level of change in self-reported stress ratings across the two conditions. It is important to note that these ratings are an imperfect measure of participants' positive mood, because (1) the type and intensity of affect aroused from life events varies considerably across individuals (e.g., graduating high school may be a momentous life event for some and a minor event for others), and (2) positive experiences can be stressful. Nonetheless, examination of the stress ratings provides some insight into whether there were demonstrable differences in how patients and controls reacted to the task. Patients showed an increase in self-reported stress from the affective-neutral to the positive condition (29.82 Ϯ 25.47 and 37.84 Ϯ 30.72, respectively), while controls showed a slight decrease (23.04 Ϯ 19.51 and 22.29 Ϯ 22.04, respectively). The main effect for group was statistically significant (F ͓1͔ ϭ 169.14, p Ͻ 0.00), the main effect for condition was not significant (F ͓98͔ ϭ 1.96, NS), and the interaction was significant at the trend level (f ͓98͔ ϭ 2.87, p ϭ 0.09). Simple contrasts revealed that, compared with the controls, patients reported both conditions as being more stressful. However, patients and controls were marginally but nonsignificantly different in the level of change in selfreported stress across the two conditions, providing some assurance that the lack of group differences in speech disorder reactivity was not due to group differences in affect arousal.
Examining the Variability in Speech Disorder Reactivity for Patients
For both groups of participants, there was considerable variability in whether speech disorder ratings increased or decreased when positive affect was aroused. Approximately half of controls (54%) and patients (61%) had lower speech disorder ratings in the positive condition versus the neutral condition. To examine whether there were individual differences between patients whose speech disorder exacerbated versus those whose speech disorder ameliorated, participants were trichotomized into one of three groups: (1) participants whose speech disorder ameliorated when positive affect was elicited (i.e., showed a decrease of .5 or more instances of speech disorder per hundred words on the positive versus neutral conditions), (2) participants whose speech disorder exacerbated (i.e., showed an increase of .5 or more instances of speech disorder per hundred words on the positive versus neutral conditions), and (3) participants who showed a negligible difference between the two conditions (e.g., all other patients). Although the .5 criterion was somewhat arbitrary, it
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The Journal of Nervous and Mental Disease • Volume 193, Number 12, December 2005 appeared to be a meaningful cutoff because it parsed the patient group into three roughly equal groups for betweengroup analysis. The validity of this criterion was bolstered by the finding that 85% of the controls had change scores in the negligible range. Thirty-seven percent (N ϭ 21; mean change ϭ 1.89 Ϯ 1.76) of the patients showed marked levels of speech disorder amelioration, 26% (N ϭ 15; mean change ϭ 1.37 Ϯ 1.40) of the patients showed marked levels of speech disorder exacerbation, and 37% (N ϭ 21; mean change ϭ .08 Ϯ .30) of the patients showed negligible changes in speech disorder across the two conditions. Symptom factor, demographic, clinical, and medication data were then compared between the three groups using a series of one-way ANOVAs with Scheffé post hoc tests. These results are presented in Table 1 . Patients whose speech disorder ameliorated versus those whose speech disorder exacerbated had significantly more severe psychotic and total psychiatric symptoms and a trend for more severe manic/ excitement symptoms. The three groups did not differ on any of the descriptive, clinical, or medication data, or anergia or depression/anxiety symptom severity scores. In sum, patients whose speech disorder ameliorated when positive affect was aroused tended to have more severe psychotic and overall symptomatology compared with patients whose speech disorder exacerbated, but there were no other substantive between-group differences noted.
The self-reported stress scores were then examined between the three groups using a mixed model ANOVA. All three groups showed a slight increase in stress scores from the affective neutral to the positive condition, including patients who showed speech disorder amelioration (25.30 Ϯ 26.52 and 34.80 Ϯ 37.53, respectively), speech disorder exacerbation (39.29 Ϯ 26.79 and 45.07 Ϯ 25.26, respectively) , and negligible speech changes (27.81 Ϯ 23.01 and 35.90 Ϯ 27.31, respectively) . The main effect for condition was significant at a trend level (F ͓52͔ ϭ 3.84, p ϭ 0.06), but neither the group (F ͓2͔ ϭ 1.14, NS) nor the interaction (f ͓52͔ ϭ .07, NS) effects were significant. Thus, patients in all three groups, on average, reported a similar level of increase in stress arousal during the positive condition.
DISCUSSION
This study is the first to examine the effects of positive affect on speech disorder in patients with schizophrenia using a laboratory paradigm. For participants as a group, the arousal of positive affect did not change speech disorder in a discernible manner. This was largely because there was considerable variability across patients in how their level of speech disorder changed. A subgroup of patients evidenced relatively marked amelioration in their speech disorder, while a separate and somewhat smaller subgroup of patients evidenced speech disorder exacerbation. Post hoc analyses revealed that the ameliorating patients tended to have more severe psychotic and overall psychiatric symptomatology compared with patients whose speech disorder worsened in the positive condition. Although these secondary analyses were underpowered, results suggest that certain patients with relatively high levels of symptomatology, notably psychotic symptoms, can show speech disorder amelioration through positive mood induction.
The notion that arousal of positive affect may influence symptomatology in some patients has important implications for future research. For example, explicating the neurophysiological effects of positive affect arousal may help to clarify which brain systems contribute to symptom reactivity more generally. Moreover, further understanding of the differences between patients who show symptom amelioration from arousal of positive affect and those who do not may help to explain the variability in treatment response across patients. It is important to note that the present study was exploratory in design, so it would be important to replicate these findings in another sample. Nonetheless, a call for further understanding of the mechanism by which positive affect influences symptoms is warranted.
